Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 9/20 | 0.87 |
| ▸ | TSHR | P16473 | 3/20 | 0.87 |
| ▸ | MEN1 | O00255 | 1/20 | 0.87 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.87 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.87 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.87 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA3 | P07451 | 2/20 | 0.53 |
| ▸ | CA4 | P22748 | 2/20 | 0.53 |
| ▸ | CA6 | P23280 | 2/20 | 0.53 |
| ▸ | CA5A | P35218 | 2/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.53 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetradecylamine SCHEMBL17238770 | 1.00 | DNM1 (0.87) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Methyl Alcohol SCHEMBL28365635 | 1.00 | — | — | |
| Dodecylamine SCHEMBL25308253 | 1.00 | DNM1 (0.87) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Octadecylamine SCHEMBL27855291 | 1.00 | DNM1 (0.87) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Methyl Alcohol SCHEMBL27629047 | 0.97 | DNM1 (0.81) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Methyl Alcohol SCHEMBL28847801 | 0.97 | DNM1 (0.88) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Hexadecylamine SCHEMBL28465652 | 0.97 | DNM1 (0.88) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Methyl Alcohol SCHEMBL28223334 | 0.97 | — | — | |
| Dodecylamine SCHEMBL30648425 | 0.93 | DNM1 (0.87) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Hydrogen Peroxide SCHEMBL28195629 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107334733-B | Gambogic acid-containing reduction-sensitive compound and preparation method and application thereof | 山东省千佛山医院 | 2020-06-05 | — | — | CN | claimed |
| CN-115838346-B | Method for synthesizing N, N '-dialkyl-3, 3' -dithiodipropionamide by one-pot method | 大连百傲化学股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-107334733-B | Gambogic acid-containing reduction-sensitive compound and preparation method and application thereof | 山东省千佛山医院 | 2020-06-05 | — | — | CN | disclosed |
| CN-107334733-A | A kind of reduction responsive type compound containing gambogicacid and its preparation method and application | 山东省千佛山医院 | 2017-11-10 | — | — | CN | disclosed |
| CN-106581686-A | Preparation and application of hyaluronic acid-modified amphipathic chitosan derivative carrier with tumor microenvironment specificity drug release effect | 中国药科大学 | 2017-04-26 | — | — | CN | disclosed |
| EP-1753710-B1 | PROCESS FOR FORMING BRANCHED COMPOSITION CATALYTICALLY BY CARBON-HYDROGEN BOND ACTIVATION IN A SATURATED MOIETY | AKZO NOBEL NV (NL) | 2010-12-22 | — | — | EP | disclosed |
| US-7227040-B2 | Process for forming branched composition catalytically by carbon-hydrogen bond activation in a saturated moiety | AKZO NOBEL N.V. (NL) | 2007-06-05 | — | — | US | disclosed |
| US-20050272941-A1 | Process for forming branched composition catalytically by carbon-hydrogen bond activation in a saturated moiety | AKZO NOBEL N.V. (NL) | 2005-12-08 | — | — | US | disclosed |
| CN-1136848-C | Application of bilirubin bitaurine sodium and its bilirubin derivative in preparing anti-HIV medicine | 中国科学院化学研究所 | 2004-02-04 | — | — | CN | disclosed |
| CN-1315176-A | Application of bilirubin bitaurine sodium and its bilirubin derivative in preparing anti-HIV medicine | INST PHOTOSENSITIVE CHEMISTRY CAS (CN) | 2001-10-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050272941-A1 | Process for forming branched composition catalytically by carbon-hydrogen bond activation in a saturated moiety | SCO2, HAO2, SOD1 | DNM1 855/4885TSHR 4662/4885MEN1 2279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.